Free Trial

Enhabit (NYSE:EHAB) EVP Sells $38,068.59 in Stock

Enhabit logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Insider sale: Enhabit EVP Julie Diane Jolley sold 2,793 shares on March 9 at an average price of $13.63 for proceeds of $38,068.59, cutting her stake by 1.96% to 139,923 shares; the transaction was disclosed in an SEC filing.
  • Stock and analyst snapshot: EHAB traded at $13.62 (up 0.1%) with a market cap of $690.6M and a negative P/E of -151.28; the company reported Q4 EPS of $0.14 in line with estimates and analysts' consensus is a Hold with an average price target of $13.57 (2 Buy, 6 Hold, 1 Sell).
  • Five stocks to consider instead of Enhabit.

Enhabit, Inc. (NYSE:EHAB - Get Free Report) EVP Julie Diane Jolley sold 2,793 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares in the company, valued at approximately $1,907,150.49. This represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Enhabit Stock Up 0.1%

NYSE:EHAB traded up $0.02 during trading hours on Wednesday, reaching $13.62. The company had a trading volume of 2,806,514 shares, compared to its average volume of 2,568,830. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $13.68. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. The firm has a market cap of $690.55 million, a price-to-earnings ratio of -151.28 and a beta of 1.56. The business's 50-day simple moving average is $11.39 and its two-hundred day simple moving average is $9.49.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. The firm had revenue of $270.40 million for the quarter, compared to analyst estimates of $270.56 million. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. On average, equities analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its holdings in Enhabit by 115.6% during the 1st quarter. AQR Capital Management LLC now owns 215,341 shares of the company's stock valued at $1,867,000 after buying an additional 115,456 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Enhabit by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company's stock worth $262,000 after purchasing an additional 1,248 shares during the last quarter. Jones Financial Companies Lllp increased its position in shares of Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company's stock worth $78,000 after purchasing an additional 8,879 shares during the last quarter. Empowered Funds LLC raised its stake in Enhabit by 8.4% in the first quarter. Empowered Funds LLC now owns 190,514 shares of the company's stock valued at $1,675,000 after purchasing an additional 14,690 shares in the last quarter. Finally, Acadian Asset Management LLC bought a new stake in Enhabit during the first quarter valued at approximately $114,000.

Analyst Ratings Changes

EHAB has been the subject of a number of research reports. TD Cowen reissued a "hold" rating and issued a $13.80 price objective (up from $12.00) on shares of Enhabit in a research note on Friday, March 6th. Truist Financial set a $13.80 target price on Enhabit in a report on Monday, February 23rd. Oppenheimer downgraded shares of Enhabit from an "outperform" rating to a "market perform" rating in a research report on Monday, February 23rd. Leerink Partners boosted their price target on shares of Enhabit from $9.50 to $13.80 and gave the company a "market perform" rating in a research note on Monday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a "buy" rating in a research note on Tuesday, January 13th. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Enhabit currently has an average rating of "Hold" and a consensus price target of $13.57.

Read Our Latest Stock Analysis on Enhabit

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc NYSE: EHAB is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines